[Calcium channel blockers. Review and attempt at classification].
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use*; D002312:Cardiomyopathy, Hypertrophic / Q000188:drug therapy; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D055598:Chemical Phenomena; D002621:Chemistry; D003327:Coronary Disease / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D011817:Rabbits; D013329:Structure-Activity Relationship; D014665:Vasodilator Agents / Q000009:adverse effects / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D002121:Calcium Channel Blockers; D014665:Vasodilator Agents
Bloqueadores de la entrada del calcio. Revisión e intento de clasificación.